Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 6, 2008, Pages 613.e1-613.e9

  Donders, Gilbert ^a,b   Bellen, Gert ^a   Byttebier, Geert ^c   Verguts, Luc ^d   Hinoul, Piet ^e   Walckiers, Ronald ^f   Stalpaert, Michel ^g   Vereecken, Annie ^g   Van Eldere, Johan ^b  

^a Femicare vzw   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c General Biometric Services and Consulting   (Belgium)

^d Department of Obstetrics and Gynaecology ^*  (Belgium)

^e DEPARTMENT OF CARDIOLOGY   (Belgium)

^f Algemeen Ziekenhuis Waasland   (Belgium)

^g Algemeen Medisch Laboratorium   (Belgium)

Author keywords

candidiasis; chronic disease; fluconazole; prophylactic treatment; vaginitis

Indexed keywords

FLUCONAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; BREAST DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EAR NOSE THROAT DISEASE; FEMALE; FEVER; FUNGAL COLONIZATION; FUNGUS CULTURE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MENTAL DISEASE; MICROSCOPY; MINERAL DEFICIENCY; MORBIDITY; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; PATHOGENESIS; PELVIC DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SKIN DISEASE; STOMACH PAIN; TOENAIL ONYCHOMYCOSIS; TOOTH DISEASE; TREATMENT RESPONSE; URINARY TRACT DISEASE; VAGINA BLEEDING; VAGINA CANDIDIASIS; VITAMIN DEFICIENCY;

EID: 57149148098     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.06.029     Document Type: Article

References (12)

1. Stewart D.E., Whelan C.I., Fong I.W., and Tessler K.M. Psychosocial aspects of chronic, clinically unconfirmed vulvovaginitis. Obstet Gynecol 76 (1990) 852-856
2. Sobel J.D., Wiesenfeld H.C., Martens M., et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 351 (2004) 876-883
3. Larsson P.G., and Platz-Christensen J.J. Enumeration of clue cells in rehydrated air-dried vaginal wet smears for the diagnosis of bacterial vaginosis. Obstet Gynecol 76 (1990) 727-730
4. Donders G.G. Microscopy of the bacterial flora on fresh vaginal smears. Infect Dis Obstet Gynecol 7 (1999) 177-179
5. Donders G.G., Vereecken A., Bosmans E., Dekeersmaecker A., Salembier G., and Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109 (2002) 34-43
6. Massonet C., Van E.J., Vaneechoutte M., De B.T., Verhaegen J., and Lagrou K. Comparison of VITEK 2 with ITS2-fragment length polymorphism analysis for identification of yeast species. J Clin Microbiol 42 (2004) 2209-2211
7. Kosonen J., Rantala A., Little C.H., et al. Increased levels of Candida albicans mannan-specific T-cell-derived antigen binding molecules in patients with invasive candidiasis. Clin Vaccine Immunol 13 (2006) 467-474
8. Fidel Jr. P.L., Barousse M., Lounev V., Espinosa T., Chesson R.R., and Dunlap K. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle. Med Mycol 41 (2003) 97-109
9. De B.F., Santoni G., Boccanera M., et al. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun 68 (2000) 3297-3304
10. Corrigan E.M., Clancy R.L., Dunkley M.L., Eyers F.M., and Beagley K.W. Cellular immunity in recurrent vulvovaginal candidiasis. Clin Exp Immunol 111 (1998) 574-578
11. Bauters T.G., Dhont M.A., Temmerman M.I., and Nelis H.J. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol 187 (2002) 569-574
12. Richter S.S., Galask R.P., Messer S.A., Hollis R.J., Diekema D.J., and Pfaller M.A. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 43 (2005) 2155-2162